Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone.

Slides:

Advertisements

Similar presentations

Age-specific serum anti-Müllerian hormone values for 17,120 women presenting to fertility centers within the United States David B. Seifer, M.D., Valerie.

Advertisements

Fertility preservation in pre-pubertal girls with cancer: the role of ovarian tissue cryopreservation W. Hamish B. Wallace, M.D., Thomas W. Kelsey, Ph.D.,

Direct vitamin D3 actions on rhesus macaque follicles in three-dimensional culture: assessment of follicle survival, growth, steroid, and antimüllerian.

Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.

Yuqian Cui, M. D. , Ph. D. , Yuhua Shi, M. D. , Ph. D. , Linlin Cui, M

Obstetric and perinatal outcomes in singleton pregnancies resulting from the transfer of blastocyst-stage versus cleavage-stage embryos generated through.

Goserelin fosters bone elongation but does not prevent ovarian damage in cyclophosphamide-treated prepubertal mice Laura Detti, M.D., Rebecca A. Uhlmann,

S.M. Nelson, A. La Marca Reproductive BioMedicine Online

A new menstrual pictogram for use with feminine products that contain superabsorbent polymers Julia L. Magnay, M.Sc., Tracy M. Nevatte, Ph.D., Christian.

Safety and feasibility of performing two consecutive ovarian stimulation cycles with the use of letrozole-gonadotropin protocol for fertility preservation.

Karl R. Hansen, M. D. , Ph. D. , George M. Hodnett, M. D

Infertility evaluation and treatment among women in the United States

H. Irene Su, M. D. , M. S. C. E. , Mary D. Sammel, Sc. D. , Michael V

Thyroid antibodies and gestational diabetes mellitus: a meta-analysis

The association between circulating levels of antimüllerian hormone and follicle number, androgens, and menstrual cycle characteristics in young women

Mike Ripley, M. D. , F. R. C. S. C. , Andrea Lanes, M. Sc

Janet Kwee, M. D. , Roel Schats, M. D. , Ph. D. , Joseph McDonnell, M

Patient-tailored ovarian stimulation for in vitro fertilization

What is the optimal follicular size before triggering ovulation in intrauterine insemination cycles with clomiphene citrate or letrozole? An analysis.

Antimüllerian hormone: correlation with age and androgenic and metabolic factors in women from birth to postmenopause Linlin Cui, M.D., Ph.D., Yingying.

Comparative assessment of five serum antimüllerian hormone assays for the diagnosis of polycystic ovary syndrome Pascal Pigny, Ph.D., Elisse Gorisse,

Ethnicity as a determinant of ovarian reserve: differences in ovarian aging between Spanish and Indian women Carlos Iglesias, M.D., Manish Banker, M.D.,

Role of ovarian reserve markers, antimüllerian hormone and antral follicle count, as aneuploidy markers in ongoing pregnancies and miscarriages Maribel.

Contribution of the rate of change of antimüllerian hormone in estimating time to menopause for late reproductive-age women Ellen W. Freeman, Ph.D.,

Antimüllerian hormone levels and antral follicle count as prognostic indicators in a personalized prediction model of live birth Scott M. Nelson, M.R.C.O.G.,

Antimüllerian hormone as a predictor of live birth following assisted reproduction: an analysis of 85,062 fresh and thawed cycles from the Society for.

Antimüllerian hormone levels and antral follicle counts are not reduced compared with community controls in patients with rigorously defined unexplained.

Antral follicle count as a predictor of ovarian responsiveness in women with endometriomas or with a history of surgery for endometriomas Laura Benaglia,

The role of antimullerian hormone in prediction of outcome after IVF: comparison with the antral follicle count Simone L. Broer, B.Sc., Ben Willem J.

Carbon dioxide versus normal saline as distension medium for diagnostic hysteroscopy: a systematic review and meta-analysis of randomized controlled trials

Biomarkers of ovarian response: current and future applications

How old is too old? Challenges faced by clinicians concerning age cutoffs for patients undergoing in vitro fertilization Robert L. Klitzman, M.D. Fertility.

Antral follicle count: absence of significant midlife decline

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

Diminished ovarian reserve as measured by means of baseline follicle-stimulating hormone and antral follicle count is not associated with pregnancy loss.

Evaluating the performance of serum antimullerian hormone concentration in predicting the live birth rate of controlled ovarian stimulation and intrauterine.

Cervical mucus removal before embryo transfer in women undergoing in vitro fertilization/intracytoplasmic sperm injection: a systematic review and meta-analysis.

Paweł Jóźków, M. D. , Ph. D. , Marek Mędraś, M. D. , Ph. D

Albert Hsu, M. D. , Margaret Arny, Ph. D. , Alexander B. Knee, M. S

Microdose flare protocol with interrupted follicle stimulating hormone and added androgen for poor responders—an observational pilot study Frederic Mitri,

Links between age at menarche, antral follicle count, and body mass index in African American and European American women Sonya M. Schuh, Ph.D., Julia.

Dynamic antimüllerian hormone levels during controlled ovarian hyperstimulation predict in vitro fertilization response and pregnancy outcomes Aaron.

Sean Ackerman, M. D. , Julia Wenegrat, M. A. , David Rettew, M. D

Benny Almog, M. D. , Fady Shehata, M. B. , B. Ch. , M. Sc

Tomer Singer, M. D. , David H. Barad, M. D. , M. S

Antimüllerian hormone as predictor of implantation and clinical pregnancy after assisted conception: a systematic review and meta-analysis Reshef Tal,

Clomiphene citrate at 50: the dawning of assisted reproduction

Akanksha Mehta, M.D., Darius A. Paduch, M.D., Ph.D.

Antimüllerian hormone and antral follicle count are lower in female cancer survivors and healthy women taking hormonal contraception Lauren N.C. Johnson,

Fertile lifespan characteristics and all-cause and cause-specific mortality among postmenopausal women: the Rotterdam Study Loes Jaspers, M.D., Maryam.

Prospective cohort study of three- versus two-dimensional ultrasound for prediction of oocyte maturity Doron Shmorgun, M.D., Edward Hughes, M.D., Patrick.

Clinical uses of anti-Müllerian hormone assays: pitfalls and promises

Antimüllerian hormone in gonadotropin releasing-hormone antagonist cycles: prediction of ovarian response and cumulative treatment outcome in good-prognosis.

Antral follicle counts are strongly associated with live-birth rates after assisted reproduction, with superior treatment outcome in women with polycystic.

Peter J. Stahl, M. D. , Chava Cogan, B. S. , Akanksha Mehta, M. D

Impact of subclinical hypothyroidism in women with recurrent early pregnancy loss Lia A. Bernardi, M.D., Ronald N. Cohen, M.D., Mary D. Stephenson, M.D.,

Genetic evaluation procedures at sperm banks in the United States

A woman with premature ovarian failure induced by Tripterygium wilfordii Hook.f. gives birth to a healthy child Xin Chen, M.D., M.Sc., Shi-ling Chen,

Nomogram for the decline in serum antimüllerian hormone: a population study of 9,601 infertility patients Scott M. Nelson, Ph.D., Martina C. Messow,

David H. Barad, M.D., M.S., Norbert Gleicher, M.D.

Comparing anti-Müllerian hormone (AMH) and follicle-stimulating hormone (FSH) as predictors of ovarian function David H. Barad, M.D., M.S., Andrea Weghofer,

Cem Fiçicioǧlu, M. D. , Tayfun Kutlu, M. D. , Elif Baglam, M. D

Early menopause in mothers of children with Down syndrome?

Brooks A. Keel, Ph.D., H.C.L.D.(A.B.B.) Fertility and Sterility

Effect of methotrexate exposure on subsequent fertility in women undergoing controlled ovarian stimulation Janet F. McLaren, M.D., Richard O. Burney,

Randomized, controlled pilot trial of natural versus hormone replacement therapy cycles in frozen embryo replacement in vitro fertilization Ginny Mounce,

A prospective, comparative analysis of anti-Müllerian hormone, inhibin-B, and three- dimensional ultrasound determinants of ovarian reserve in the prediction.

Comparisons of inhibin B versus antimüllerian hormone in poor ovarian responders undergoing in vitro fertilization Rongrong Tan, M.M.Sc., Danhua Pu,

Low body mass index compromises live birth rate in fresh transfer in vitro fertilization cycles: a retrospective study in a Chinese population Jiali.

Oocyte retrieval timing based on spontaneous luteinizing hormone surge during natural cycle in vitro fertilization treatment Daniel Bodri, M.D., M.Sc.,

Presentation transcript:

Modification of the Beckman-Coulter second-generation enzyme-linked immunosorbent assay protocol improves the reliability of serum antimüllerian hormone measurement Laurentiu Craciunas, Dr.-Med., Stephen A. Roberts, Ph.D., Allen P. Yates, Ph.D., Alexander Smith, Ph.D., Cheryl Fitzgerald, M.D., Philip W. Pemberton, M.Sc. Fertility and Sterility Volume 103, Issue 2, Pages 554-559.e1 (February 2015) DOI: 10.1016/j.fertnstert.2014.10.052 Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 1 Modified second-generation (Gen IIm) antimüllerian hormone (AMH) measurement versus original second-generation (Gen II) assay. The thick line shows the best fit with a simple conversion factor (1.51, 95% confidence interval 1.44–1.58). The thin lines show equivalence (solid line) and a conversion factor of 2 (dashed line). Fertility and Sterility 2015 103, 554-559.e1DOI: (10.1016/j.fertnstert.2014.10.052) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Figure 2 Gen I, Gen II, and Gen IIm AMH versus age. Plots of antimüllerian hormone (AMH) concentration (pmol/L) against age (years) for the first-generation Diagnostic Systems Laboratories (Gen I) assay, the original (Gen II) and the modified (Gen IIm) second-generation assays, with the use of linear regression with a quadratic age function. Fertility and Sterility 2015 103, 554-559.e1DOI: (10.1016/j.fertnstert.2014.10.052) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions

Supplemental Figure 1 Modified second-generation (Gen IIm) antimüllerian hormone (AMH) measurement versus antral follicle count (AFC). The line is a linear fit: log(AMH) = −1.41 + 1.59 log(AFC + 0.5). Fertility and Sterility 2015 103, 554-559.e1DOI: (10.1016/j.fertnstert.2014.10.052) Copyright © 2015 American Society for Reproductive Medicine Terms and Conditions